ArticleBreast cancer research and treatment2022

Dose-dependent relation between metformin and the risk of hormone receptor-positive, her2-negative breast cancer among postmenopausal women with type-2 diabetes.

Soumya G Chikermane et al.PubMed ↗Publisher ↗

No numbers read from the abstract.